Pacira BioSciences Inc. (NASDAQ:PCRX) is one of the most undervalued small-cap stocks to buy according to analysts.

Pacira BioSciences Inc. (NASDAQ: PCRX) is one of the most undervalued small-cap stocks to buy according to analysts. On June 11, Pacira BioSciences announced new long-term follow-up data from its ...

The 2024 EULAR recommendations provide updated guidance on the safe use of antirheumatic drugs in reproduction, pregnancy and lactation — timely given the expansion of available therapies.

From drug trials to mechanistic insights, EULAR 2025 delivers wide-ranging data that may inform tomorrow’s standards in rheumatology care.

According to a EULAR press release, the data “suggest the potential for CAR T-cell therapy and other B-cell depleting therapies to reset the immune system in multiple RMD, allowing patients to ...

Kioxia today announced an update to its KIOXIA AiSAQ software, allowing balance specific workloads in RAG systems without hardware modifications.

Considering Vector for a home security system? Learn more about the company’s plans and pricing. Compare verified reviews and complaints.

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus erythematosus (SLE) have been revealed, and have not disappointed ...

CUTCO Cutlery — Vector Marketing specializes in kitchen cutlery and direct sales. CUTCO manufactures knives, kitchen tools and accessories, while Vector Marketing handles sales and distribution.

Genetic vectors articles from across Nature Portfolio Atom RSS Feed Genetic vectors are vehicles for delivering foreign DNA into recipient cells. Vectors can replicate autonomously and typically ...

Business Wire Merck Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025 12 Jun 2025 DARMSTADT, Germany Not intended for UK-, US- or Canada ...

EULAR 2025 EULAR, ERS Issue First Guideline for Managing CTD-ILD The guidelines include disease-specific recommendations on screening, monitoring disease progression, and treatment options for ILD.